Developing a powerful NMR magnet for improved sensitivity and resolution in spectroscopy
A high-resolution 1.3-GHz LTS/HTS NMR magnet (1.3G)
This study is working on a new type of magnet that will make it easier to see tiny details in biological and chemical samples, which could lead to better tests and treatments for patients in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10675082 on NIH RePORTER |
What this research studies
This research focuses on creating a high-resolution nuclear magnetic resonance (NMR) magnet that operates at 1.3 GHz, which is significantly higher than current technologies. By combining low-temperature and high-temperature superconducting magnets, the project aims to enhance the sensitivity and resolution of NMR spectroscopy, allowing for better analysis of biological and chemical samples. The methodology involves advanced engineering techniques to achieve the necessary magnetic field strength and homogeneity required for precise measurements. Patients may benefit indirectly from improved diagnostic tools and research capabilities that arise from this technology.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that require advanced diagnostic imaging or analysis, such as cancer or neurological disorders.
Not a fit: Patients with conditions that do not require advanced imaging techniques or those who are not undergoing diagnostic procedures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnostic tools and better understanding of biological processes, ultimately improving patient care.
How similar studies have performed: Other research has shown success with similar high-frequency NMR technologies, indicating a promising potential for this approach.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Iwasa, Yukikazu — Massachusetts Institute of Technology
- Study coordinator: Iwasa, Yukikazu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.